0
0
0
0
1
2
3
$0
Is Colgate-Palmolive solid or fragile? The Finex Financial Health Scanner reads CL's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $20.4B |
|---|---|
| Net income | $2.1B |
| Operating margin | 16.2% |
| Net margin | 10.5% |
| Cash and investments | $1.3B |
| Total debt | $8.0B |
| Free cash flow | $3.4B |
| Revenue growth (1 year) | 1.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.